shortagewatch

Home / Cancer and immune system / Etoposide

ATC L01CB01 · Antineoplastic Agents

Etoposide shortage

As of 31 Oct 2026, Etoposide has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 5 products.

Countries2/5
Products5packs or presentations
Short since30 Jun 20264 months ago
Earliest return31 Jan 2027company estimate
No return date4products
Main reasonManufacturing problem
GermanyNo reported shortageItaly4 packs shortSpainNo reported shortageAustriaNo reported shortageBelgium1 pack short

Timeline

ItalyBelgium
2027ETOPOSIDE TEVAETOPOSIDE TEVAETOPOSIDE ACCORDETOPOSIDE ACCORDEtoposide Accord Healthcare 20 mg/ml inf. soEtoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial 12.5 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITETOPOSIDE TEVATEVA PHARMA B.V.30 Jun 2026not givenManufacturing problem
Problemi produttivi
ITETOPOSIDE ACCORDACCORD HEALTHCARE, S.L.U.2 Oct 2026not givenIncreased demand
Elevata richiesta
ITETOPOSIDE SANDOZ announcedSANDOZ S.P.A.2 Nov 2026not givenManufacturing problem
Problemi produttivi
ITETOPOSIDE ACCORD announcedACCORD HEALTHCARE, S.L.U.6 Nov 2026not givenIncreased demand
Elevata richiesta
BEEtoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial 12.5 mlAccord Healthcare14 Aug 202631 Jan 2027Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.